Clinical trials
Terminated Phase 2 Anemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 6 |
| 2006 | 4 |
| 2007 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 9 |
| Merck Sharp & Dohme LLC | 4 |
| Affymax | 3 |
| Aevi Genomic Medicine, LLC, a Cerecor company | 2 |
| GlaxoSmithKline | 2 |
| University of Leipzig | 2 |
| Akebia Therapeutics | 1 |
| Amgen | 1 |
| Baxalta now part of Shire | 1 |
| Duke University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 43 |
| Kidney Failure, Chronic | 7 |
| Renal Insufficiency, Chronic | 7 |
| Neoplasms | 6 |
| Myelodysplastic Syndromes | 5 |
| Neutropenia | 2 |
| Primary Myelofibrosis | 2 |
| Thrombocytopenia | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Anemia, Iron-Deficiency | 1 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.